81 related articles for article (PubMed ID: 28081228)
21. Regulation of the G2/M transition by p53.
Taylor WR; Stark GR
Oncogene; 2001 Apr; 20(15):1803-15. PubMed ID: 11313928
[TBL] [Abstract][Full Text] [Related]
22. Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome.
Mirzayans R; Andrais B; Kumar P; Murray D
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28452953
[TBL] [Abstract][Full Text] [Related]
23. Resistance for Genotoxic Damage in Mesenchymal Stromal Cells Is Increased by Hypoxia but Not Generally Dependent on p53-Regulated Cell Cycle Arrest.
Lützkendorf J; Wieduwild E; Nerger K; Lambrecht N; Schmoll HJ; Müller-Tidow C; Müller LP
PLoS One; 2017; 12(1):e0169921. PubMed ID: 28081228
[TBL] [Abstract][Full Text] [Related]
24. Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells.
Vera J; Raatz Y; Wolkenhauer O; Kottek T; Bhattacharya A; Simon JC; Kunz M
Cell Signal; 2015 May; 27(5):951-60. PubMed ID: 25683911
[TBL] [Abstract][Full Text] [Related]
25. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells.
Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH
Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784
[TBL] [Abstract][Full Text] [Related]
26. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
[TBL] [Abstract][Full Text] [Related]
27. c-ABL tyrosine kinase modulates p53-dependent p21 induction and ensuing cell fate decision in response to DNA damage.
Udden SM; Morita-Fujimura Y; Satake M; Ikawa S
Cell Signal; 2014 Feb; 26(2):444-52. PubMed ID: 24177958
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.
Sarin N; Engel F; Kalayda GV; Mannewitz M; Cinatl J; Rothweiler F; Michaelis M; Saafan H; Ritter CA; Jaehde U; Frötschl R
PLoS One; 2017; 12(7):e0181081. PubMed ID: 28746345
[TBL] [Abstract][Full Text] [Related]
29. Multipotent mesenchymal stromal cells promote tumor growth in distinct colorectal cancer cells by a β1-integrin-dependent mechanism.
Widder M; Lützkendorf J; Caysa H; Unverzagt S; Wickenhauser C; Benndorf RA; Schmoll HJ; Müller-Tidow C; Müller T; Müller LP
Int J Cancer; 2016 Feb; 138(4):964-75. PubMed ID: 26356035
[TBL] [Abstract][Full Text] [Related]
30. Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate.
Scala F; Brighenti E; Govoni M; Imbrogno E; Fornari F; Treré D; Montanaro L; Derenzini M
Oncogene; 2016 Feb; 35(8):977-89. PubMed ID: 25961931
[TBL] [Abstract][Full Text] [Related]
31. Effect of high-dose irradiation on human bone-marrow-derived mesenchymal stromal cells.
Fekete N; Erle A; Amann EM; Fürst D; Rojewski MT; Langonné A; Sensebé L; Schrezenmeier H; Schmidtke-Schrezenmeier G
Tissue Eng Part C Methods; 2015 Feb; 21(2):112-22. PubMed ID: 24918644
[TBL] [Abstract][Full Text] [Related]
32. The bone marrow niche for haematopoietic stem cells.
Morrison SJ; Scadden DT
Nature; 2014 Jan; 505(7483):327-34. PubMed ID: 24429631
[TBL] [Abstract][Full Text] [Related]
33. Mesenchymal stromal cells: sensors and switchers of inflammation.
Bernardo ME; Fibbe WE
Cell Stem Cell; 2013 Oct; 13(4):392-402. PubMed ID: 24094322
[TBL] [Abstract][Full Text] [Related]
34. DNA damage in stem cells activates p21, inhibits p53, and induces symmetric self-renewing divisions.
Insinga A; Cicalese A; Faretta M; Gallo B; Albano L; Ronzoni S; Furia L; Viale A; Pelicci PG
Proc Natl Acad Sci U S A; 2013 Mar; 110(10):3931-6. PubMed ID: 23417300
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal stromal cells: radio-resistant members of the bone marrow.
Sugrue T; Lowndes NF; Ceredig R
Immunol Cell Biol; 2013 Jan; 91(1):5-11. PubMed ID: 23165606
[TBL] [Abstract][Full Text] [Related]
36. Sarcomas as a mise en abyme of mesenchymal stem cells: exploiting interrelationships for cell mediated anticancer therapy.
Burns JS; Safwat A; Grisendi G; Kassem M; Dominici M
Cancer Lett; 2012 Dec; 325(1):1-10. PubMed ID: 22659735
[TBL] [Abstract][Full Text] [Related]
37. Atmospheric oxygen inhibits growth and differentiation of marrow-derived mouse mesenchymal stem cells via a p53-dependent mechanism: implications for long-term culture expansion.
Boregowda SV; Krishnappa V; Chambers JW; Lograsso PV; Lai WT; Ortiz LA; Phinney DG
Stem Cells; 2012 May; 30(5):975-87. PubMed ID: 22367737
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
